A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar

FHI 3601 site in 1 country621 target enrollmentOctober 2010

Overview

Brief Summary

This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.

Detailed Description

This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.

Registry

clinicaltrials.gov

Start Date

October 2010

End Date

March 2012

Last Updated

13 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

FHI 360

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•be a participant of the MSM service evaluation and continue using Zarin at 3 months
•agree at the time of Zarin insertion to be contacted regarding an opportunity to participate in more research related to the implant